Oral and Pharyngeal Cancer Branch, NIDCR, National Institutes of Health, Bethesda, Maryland 20892, USA.
J Biol Chem. 2012 Jan 20;287(4):2579-90. doi: 10.1074/jbc.M111.309633. Epub 2011 Nov 29.
Bacterial elongation factor P (EF-P) is the ortholog of archaeal and eukaryotic initiation factor 5A (eIF5A). EF-P shares sequence homology and crystal structure with eIF5A, but unlike eIF5A, EF-P does not undergo hypusine modification. Recently, two bacterial genes, yjeA and yjeK, encoding truncated homologs of class II lysyl-tRNA synthetase and of lysine-2,3-aminomutase, respectively, have been implicated in the modification of EF-P to convert a specific lysine to a hypothetical β-lysyl-lysine. Here we present biochemical evidence for β-lysyl-lysine modification in Escherichia coli EF-P and for its role in EF-P activity by characterizing native and recombinant EF-P proteins for their modification status and activity in vitro. Mass spectrometric analyses confirmed the lysyl modification at lysine 34 in native and recombinant EF-P proteins. The β-lysyl-lysine isopeptide was identified in the exhaustive Pronase digests of native EF-P and recombinant EF-P isolated from E. coli coexpressing EF-P, YjeA, and YjeK but not in the digests of proteins derived from the vectors encoding EF-P alone or EF-P together with YjeA, indicating that both enzymes, YjeA and YjeK, are required for β-lysylation of EF-P. Endogenous EF-P as well as the recombinant EF-P preparation containing β-lysyl-EF-P stimulated N-formyl-methionyl-puromycin synthesis ∼4-fold over the preparations containing unmodified EF-P and/or α-lysyl-EF-P. The mutant lacking the modification site lysine (K34A) was inactive. This is the first report of biochemical evidence for the β-lysylation of EF-P in vivo and the requirement for this modification for the activity of EF-P.
细菌伸长因子 P(EF-P)是古菌和真核起始因子 5A(eIF5A)的同源物。EF-P 与 eIF5A 具有序列同源性和晶体结构,但与 eIF5A 不同的是,EF-P 不经历 hypusine 修饰。最近,两个细菌基因,yjeA 和 yjeK,分别编码截断的 II 类赖氨酸 tRNA 合成酶和赖氨酸-2,3-氨基变位酶的同源物,被认为参与 EF-P 的修饰,将特定的赖氨酸转化为假设的β-赖氨酸-赖氨酸。在这里,我们通过对天然和重组 EF-P 蛋白进行修饰状态和体外活性的表征,提供了大肠杆菌 EF-P 中β-赖氨酸-赖氨酸修饰的生化证据,并证明了其在 EF-P 活性中的作用。质谱分析证实了天然和重组 EF-P 蛋白中赖氨酸 34 处的赖氨酸修饰。β-赖氨酸-赖氨酸异肽在天然 EF-P 和从共表达 EF-P、YjeA 和 YjeK 的大肠杆菌中分离的重组 EF-P 的彻底 Pronase 消化物中被鉴定出来,但不在仅编码 EF-P 或 EF-P 与 YjeA 的载体编码的蛋白质的消化物中,表明这两种酶,YjeA 和 YjeK,是 EF-P 的β-赖氨酸化所必需的。内源性 EF-P 以及含有β-赖氨酸-EF-P 的重组 EF-P 制剂比含有未修饰的 EF-P 和/或α-赖氨酸-EF-P 的制剂刺激 N-甲酰基-甲硫氨酰-嘌呤霉素合成约 4 倍。缺乏修饰位点赖氨酸(K34A)的突变体无活性。这是体内 EF-P 的β-赖氨酸化和该修饰对 EF-P 活性的要求的生化证据的首次报道。